4//SEC Filing
Collard Craig A 4
Accession 0001193125-26-016413
CIK 0000818033other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 2:39 PM ET
Size
7.0 KB
Accession
0001193125-26-016413
Insider Transaction Report
Form 4
Collard Craig A
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-19+13,797→ 536,921 total - Exercise/Conversion
Restricted Stock Units
[F2]2026-01-19−13,797→ 110,375 totalExercise: $0.00→ Common Stock (13,797 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard|2026-01-20
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001363558
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 2:39 PM ET
- Size
- 7.0 KB